Gastro Hep Advances

Gastro Hep Advances Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Gastro Hep Advances, Nonprofit Organization, Bethesda, MD.

The American Gastroenterological Association's broad-scope, online-only, open access journal for basic, clinical and translational gastroenterology and hepatology.

🖥️ Screen-detected   patients may have fewer symptoms but similar disease severity vs clinically diagnosed cases, with b...
05/28/2026

🖥️ Screen-detected patients may have fewer symptoms but similar disease severity vs clinically diagnosed cases, with both groups improving on a gluten-free diet
➡️ Highlights the potential value of early detection in
🔗 https://ow.ly/xqlP50YWFLF

⭐ New study showed variability in how dietitians manage the low FODMAP reintroduction phase. Practices differ in dosing,...
05/27/2026

⭐ New study showed variability in how dietitians manage the low FODMAP reintroduction phase. Practices differ in dosing, timing, and follow-up, underscoring the need for standardized clinical protocols.
🔗 https://ow.ly/CWmK50Z4vJE

One image can change everything ❤️‍🩹 a diagnosis, a decision, a patient’s story👨‍⚕️Share yours as Image of the Month in ...
05/25/2026

One image can change everything ❤️‍🩹 a diagnosis, a decision, a patient’s story
👨‍⚕️Share yours as Image of the Month in Gastro Hep Advances:
🧾Striking images + a concise 200-word clinical story that challenges and teaches
📮Submit today ➡️ https://ow.ly/aOVc50YYrwN
🏷️

05/23/2026

🖥️ Screening for using AFP and ultrasound scans: rising incidence and detection rates, but with same survival rates. Criteria for screening and palliation should be revised.
🔗 https://ow.ly/XJ8c50Z1S80
🏷️

hCLiP-derived small extracellular vesicles (sEVs) exert anti-fibrotic effects via their miRNA cargo. This study suggests...
05/22/2026

hCLiP-derived small extracellular vesicles (sEVs) exert anti-fibrotic effects via their miRNA cargo. This study suggests a promising cell-free therapy for liver fibrosis.
🔗 https://ow.ly/bj0x50Z1S0F
🏷️

Semaglutide eligibility is high in U.S. adults with   (80.9%), even under conventional indications. The new fibrotic MAS...
05/21/2026

Semaglutide eligibility is high in U.S. adults with (80.9%), even under conventional indications. The new fibrotic MASH approval adds modestly (51.5%→51.8%), reflecting strong overlap.
🔗 https://ow.ly/lRLe50Z1RUW
🏷️

📮 Submit your unique clinical insights to Gastro Hep Advances! Case Reports highlight intriguing, real-world cases that ...
05/20/2026

📮 Submit your unique clinical insights to Gastro Hep Advances! Case Reports highlight intriguing, real-world cases that inform and engage the GI community. Share what others can learn from your experience.
🔗 https://ow.ly/Oa1o50YYqIk
🏷️

⚠️   remains underdiagnosed in minority populations 🔎 Recent research finds Black, Hispanic, and Asian patients often ex...
05/14/2026

⚠️ remains underdiagnosed in minority populations
🔎 Recent research finds Black, Hispanic, and Asian patients often experience different or more severe symptoms, highlighting gaps in equitable screening
🔗 https://ow.ly/ytKW50YWf0L
🏷️

🔎 New insights on Clostridioides difficile infection call for a more unified, patient-centered approach, aligning diagno...
05/13/2026

🔎 New insights on Clostridioides difficile infection call for a more unified, patient-centered approach, aligning diagnostics, treatment, and outcomes to improve care across settings. Read more on the commentary ⬇️
https://ow.ly/5TRp50YYurn

Check out this article! ⬇️"Treatment Patterns, Perceptions, Barriers, and Costs in Patients With Chronic Idiopathic Cons...
05/08/2026

Check out this article! ⬇️
"Treatment Patterns, Perceptions, Barriers, and Costs in Patients With Chronic Idiopathic Constipation in the United States"
🔗 https://ow.ly/VnLa50YVhKG
🏷️

Address

Bethesda, MD
20814

Alerts

Be the first to know and let us send you an email when Gastro Hep Advances posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share